Income Tax Expense (Benefit) in USD of 180 Life Sciences Corp. from Q3 2017 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
180 Life Sciences Corp. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2017 to 2024.
  • 180 Life Sciences Corp. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was -$2.35M.
  • 180 Life Sciences Corp. annual Income Tax Expense (Benefit) for 2024 was -$296K, a 87.4% increase from 2023.
  • 180 Life Sciences Corp. annual Income Tax Expense (Benefit) for 2023 was -$2.35M, a 149% decline from 2022.
  • 180 Life Sciences Corp. annual Income Tax Expense (Benefit) for 2022 was -$943K, a 3963% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)

180 Life Sciences Corp. Quarterly Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$2.35M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q4 2021 -$23.2K -$6.62K -$1.36K -25.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$21.8K -$5.61K -$477 -9.29% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$21.4K -$5.57K -$635 -12.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$20.7K -$5.4K -$302 -5.92% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$20.4K -$5.25K +$222K +97.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$242K -$5.14K -$56.5K -110% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$186K -$4.94K -$75.4K -107% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$110K -$5.1K -$101K -105% Jan 1, 2020 Mar 31, 2020 10-Q 2021-07-19
Q4 2019 -$9.5K -$227K -$350K -284% Oct 1, 2019 Dec 31, 2019 10-K 2021-07-09
Q3 2019 $341K $51.3K -$36K -41.2% Jul 1, 2019 Sep 30, 2019 10-Q/A 2021-02-05
Q2 2019 $377K $70.4K -$55.9K -44.2% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-02-05
Q1 2019 $433K $95.8K +$19.7K +25.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-22
Q4 2018 $413K $123K Oct 1, 2018 Dec 31, 2018 10-K 2020-04-07
Q3 2018 $87.4K -$19.6K -18.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $126K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $76.2K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q3 2017 $107K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09

180 Life Sciences Corp. Annual Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$296K +$2.05M +87.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 -$2.35M -$1.41M -149% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 -$943K -$920K -3963% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-25
2021 -$23.2K -$2.78K -13.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$20.4K -$10.9K -115% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$9.5K -$423K -102% Jan 1, 2019 Dec 31, 2019 10-K 2021-07-09
2018 $413K +$218K +111% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-07
2017 $195K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.